Factors Influencing Nitroxide Reduction and Cytotoxicity In Vitro

Antioxidants and Redox Signaling

Volumn 6, Issue 3, 2004, Pages 587-595

  Samuni, Yuval ^a   Gamson, Janet ^a   Samuni, Ayelet ^a   Yamada, Kenichi ^a   Russo, Angelo ^a   Krishna, Murali C ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; HEXOSE PHOSPHATE; HYDROXYLAMINE; NITROXIDE; PHOSPHOGLUCONATE DEHYDROGENASE; TEMPOL;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON SPIN RESONANCE; HEXOSE MONOPHOSPHATE SHUNT; HUMAN; HUMAN CELL; HYPOXIC CELL; IMAGING; IN VITRO STUDY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RADIATION PROTECTION; REDUCTION; TUMOR CELL;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 2442595948     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308604773934341     Document Type: Article

References (46)

1. Belinsky SA, Reinke LA, Scholz R, Kauffman FC, and Thurman RG. Rates of pentose cycle flux in perfused rat liver. Evaluation of the role of reducing equivalents from the pentose cycle for mixed-function oxidation. Mol Pharmacol 28: 371-376, 1985.
2. Belkin S, Mehlhorn RJ, Hideg K, Hankovsky O, and Packer L. Reduction and destruction rates of nitroxide spin probes. Arch Biochem Biophys 256: 232-243, 1987.
3. Biaglow JE, Ayene IS, Koch CJ, Donahue J, Stamato TD, Mieyal JJ, and Tuttle SW. Radiation response of cells during altered protein thiol redox. Radiat Res 159: 484-494, 2003.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Branca M, Denurra T, and Turrini F. Reduction of nitroxide free radical by normal and G6PD deficient red blood cells. Free Radic Biol Med 5: 7-11, 1988.
6. Chen K and Swartz HM. Oxidation of hydroxylamines to nitroxide spin labels in living cells. Biochim Biophys Acta 970: 270-277, 1988.
7. 15N-perdeuterated Tempone. Biochim Biophys Acta 992: 131-133, 1989.
8. Chen K, Morse PD 2nd, and Swartz HM. Kinetics of enzyme-mediated reduction of lipid soluble nitroxide spin labels by lving cells. Biochim Biophys Acta 943: 477-484, 1988.
9. Chen K, Glockner JF, Morse PD, and Swartz HM. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry 28: 2496-2501, 1989.
10. Chen KY and McLaughlin MG. Differences in the reduction kinetics of incorporated spin labels in undifferentiated and differentiated mouse neuroblastoma cells. Biochim Biophys Acta 845: 189-195, 1985.
11. Comin-Anduix B, Boren J, Martinez S, Moro C, Centelles JJ, Trebukhina R, Petushok N, Lee WN, Boros LG, and Cascante M. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem 268: 4177-4182, 2001.
12. Cuscela D, Coffin D, Lupton G, Cook JA, Glass J, Krishna MC, Muldoon R, Bonner RF, and Mitchell JB. Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies. Cancer J Sci Am 2: 273-278, 1996.
13. Eriksson UG, Ogan MD, Peng CT, Brasch RC, and Tozer TN. Metabolic fate in the dog of the nitroxide moiety in a compound with potential utility as a contrast agent in MRI. Magn Reson Med 5: 73-77, 1987.
14. Gariboldi MB, Lucchi S, Caserini C, Supino R, Oliva C, and Monti E. Antiproliferative effect of the piperidine nitroxide Tempol on neoplastic and nonneoplastic mammalian cell lines. Free Radic Biol Med 24: 913-923, 1998.
15. Gariboldi MB, Ravizza R, Petterino C, Castagnaro M, Finocchiaro G, and Monti E. Study of in vitro and in vivo effects of the piperidine nitroxide Tempol - a potential new therapeutic agent for gliomas. Eur J Cancer 39: 829-837, 2003.
16. Giotta GJ and Wang HH. Reduction of nitroxide free radicals by biological materials. Biochem Biophys Res Commun 46: 1576-1580, 1972.
17. Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, and Russo A. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res 52: 1750-1753, 1992.
18. Hahn SM, Mitchell JB, and Shacter E. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage. Free Radic Biol Med 23: 879-884, 1997.
19. Hahn SM, Sullivan FJ, DeLuca AM, Krishna MC, Wersto N, Venzon D, Russo A, and Mitchell JB. Evaluation of tempol radioprotection in a murine tumor model. Free Radic Biol Med 22: 1211-1216, 1997.
20. Hu G, Lyeth BG, Zhao X, Mitchell JB, and Watson JC. Neuroprotection by the stable nitroxide 3-carbamoyl-proxyl during reperfusion in a rat model of transient focal ischemia. J Neurosurg 98: 393-396, 2003.
21. Iannone A, Hu HP, Tomasi A, Vannini V, and Swartz HM. Metabolism of aqueous soluble nitroxides in hepatocytes: effects of cell integrity, oxygen, and structure of nitroxides. Biochim Biophys Acta 991: 90-96, 1989.
22. Iannone A, Tomasi A, Vannini V, and Swartz HM. Metabolism of nitroxide spin labels in subcellular fractions of rat liver. II. Reduction by microsomes. Biochim Biophys Acta 1034: 285-289, 1990.
23. Kaplan J, Canonico PG, and Caspary WJ. Electron spin resonance studies of spin-labeled mammalian cells by detection of surface-membrane signals. Proc Natl Acad Sci U S A 70: 66-70, 1973.
24. Keana JF, Pou S, and Rosen GM. Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn Reson Med 5: 525-536, 1987.
25. Krishna MC and Samuni A. The effect of oxygen at physiological levels on the detection of free radical intermediates by electron paramagnetic resonance. Free Radic Res Commun 18: 239-247, 1993.
26. Krishna MC, Grahame DA, Samuni A, Mitchell JB, and Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci USA 89: 5537-5541, 1992.
27. Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, and Mitchell JB. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 62: 307-312, 2002.
28. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, and Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29: 2802-2807, 1990.
29. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, and Russo A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, Tempol. Arch Biochem Biophys 289: 62-70, 1991.
30. Mitchell JB, Krishna MC, Samuni A, Russo A, and Hahn SM. Nitroxides as protectors against oxidative stress. In: Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach, edited by Gilbert DL and Colton CA. New York: Plennum, 1998, pp. 293-313.
31. Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC, Hahn SM, and Russo A. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med 34: 93-102, 2003.
32. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
33. Rak R, Chao DL, Pluta RM, Mitchell JB, Oldfield EH, and Watson JC. Neuroprotection by the stable nitrioxide Tempol during reperfusion in a rat model of transient focal ischemia. J Neurosurg 92: 646-651, 2000.
34. Samuni AM, Chuang EY, Krishna MC, Stein W, DeGraff W, Russo A, and Mitchell JB. Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants. Proc Natl Acad Sci U S A 100: 5390-5395, 2003.
35. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
36. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2alpha. Hypertension 33: 424-428, 1999.
37. Stamato TD, Richardson E, Ianacone J, MacLaren RA, Denko N, and Giaccia A. Isolation and characterization of glucose-6-phosphate dehydrogenase-deficient Chinese hamster cells derived from pure mutant colonies. Mutagenesis 4: 259-264, 1989.
38. Swartz HM. Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radic Res Commun 9: 399-405, 1990.
39. Swartz HM, Chen K, Hu H, and Hideg K. Contrast agents for magnetic resonance spectroscopy: a method to obtain increased information for in vivo and in vitro spectroscopy. Mag Reson Med 22: 372-377, 1991.
40. Thiemermann C. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit Care Med 31 (Suppl): S76-S84, 2003.
41. Tietze E Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Application to mammalian blood and other tissues. Anal Biochem 27: 502-522, 1969.
42. Ueda A, Nagase S, Yokoyama H, Tada M, Noda H, Ohya H, Kamada H, Hirayama A, and Koyama A. Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical. Mol Cell Biochem 244: 119-124, 2003.
43. Welch WJ, Mendonca M, Aslam S, and Wilcox CS. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K, 1C kidney. Hypertension 41: 692-696, 2003.
44. Xavier S, Yamada K, Samuni AM, Samuni A, DeGraff W, Krishna MC, and Mitchell JB. Differential protection by nitroxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim Biophys Acta 1573: 109-120, 2002.
45. Yamada KI, Kuppusamy P, English S, Yoo J, Irie A, Subramanian S, Mitchell JB, and Krishna MC. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol 43: 433-440, 2002.
46. Zhang R, Goldstein S, and Samuni A. Kinetics of superoxide-induced exchange among nitroxide antioxidants and their oxidized and reduced forms. Free Radic Biol Med 26: 1245-1252, 1999.